Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0149871 (deep vein thrombosis)
 12,364 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Deep vein thrombosis of low extremities is the commonest complication in postsurgical urology. Difficult for diagnosis it induces thromboembolism of pulmonary artery contributing from 11.1 to 66 per cent to the rate of total postsurgical mortality. Possibility of solving the problem depends strongly on the development of efficient technique of phlebothrombosis prevention. The paper deals with the corresponding research conducted in 202 urologic patients aged from 40 to 90 years. The control group (108 persons) was subjected to routine nonspecific methods of thromboembolism prevention. The research group (94 patients) was additionally prone to the treatment with low dosages of heparin. The effect of the treatment was assessed with 125I-fibrinogen radionuclide test. Low-dosage heparin treatment resulted in a 3.3-fold decrease in the number of patients who developed postsurgery phlebothrombosis of low extremities. Incidence of thrombosis in them was 4.2-fold lower. Besides, there was a reduction in bilateral and macrofocal thrombosis incidence (11 and 11.5 times as less, respectively). The effect of the chemotherapy closely correlated with the pattern of surgical intervention and the dosage of the drug used. Low dosages of heparin (10,000 U per 24 hrs) administered to the patients with adenectomized prostate resulted in a 2.1-fold decrease in the number of those who developed deep venous thromboses of low extremities and a 3.4-fold decrease in the number of thrombosed extremities as low-dosage heparin treatment significantly influenced the incidence of bilateral thrombosis. When used as 15,000 U per 24 hrs in those patients who were exposed to lithotomy or nephrectomy the drug led to a 5-fold decrease in the incidence of phlebothrombosis.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:[Prevention of postoperative phlebothrombosis of the legs using low-dose heparin in urologic patients]. 277 83

Deep vein thrombosis and pulmonary embolism are known complications in neurosurgical patients, but prophylactic treatment is not commonly used in neurosurgical units. However the incidence of thromboembolism is comparable to general surgical patients, when reliable tests are applied. This retrospective study examines the clinical incidence of thromboembolism in 1378 neurosurgical patients. A thromboembolic complication is found in 2.6% of the patients, 1.4% of them shows pulmonary embolism. Clinical incidence seems to be small, but adjustment of heparin treatment is always difficult in neurosurgical patients and it is often insufficient. Partial inferior vena cava interruption is indicated in nearly half of the patients. Prospective studies are necessary to appreciate the incidence of deep vein thrombosis in neurosurgical patients with a reliable test. The efficiency and security of the prophylactic methods must be evaluated.
 ...
PMID:[Clinical incidence of thromboembolism in neurosurgery]. 280 58

In 160 high risk patients with total hip replacement the antithrombotic efficacy and tolerance of a single daily injection of 1500 aPTT-U (aPTT = activated partial thromboplastin time) low molecular weight heparin plus 0.5 mg dihydroergotamine (HNMD; Embolex NM) was compared with a twice daily application of 5000 IU of the heparin-dihydroergotamine combination Heparin-Dihydergot in a double-blind study. Deep vein thrombosis measured by means of the radiofibrinogen uptake test occurred in 20.5% of patients in both groups. In addition, intra- and postoperative blood loss and the development of hematoma were similar in both groups. Thus, on account of the "once-daily" application HNMD offers some substantial advantages: The stress of the patient in the postoperative convalescence phase can be appreciably lowered and thereby the nursing staff are spared a great deal of work.
 ...
PMID:Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine. 282 40

The effect of hypobaric spinal anaesthesia or narcotic-halothane-relaxant general anaesthesia on the incidence of postoperative deep vein thrombosis was studied in 140 elective total hip replacements in a prospective randomised manner. Deep vein thrombosis was diagnosed using impedance plethysmography and the 125I fibrinogen uptake test, combined, in selected cases, with ascending contrast venography. The overall incidence of deep vein thrombosis was 20%. Nine patients (13%) developed deep vein thrombosis in the spinal group and nineteen (27%) in the general anaesthetic group (p less than 0.05). The incidences of proximal thrombosis and of bilateral thrombi were also less with spinal anaesthesia than with general anaesthesia. It is concluded that spinal anaesthesia reduces the risks of postoperative thromboembolism in hip replacement surgery. The presence of varicose veins, being a non-smoker and having a low body mass index were associated with an increased incidence of deep vein thrombosis.
 ...
PMID:Deep vein thrombosis after total hip replacement. A comparison between spinal and general anaesthesia. 292 31

Deep vein thrombosis (DVT) detectable by the 99mTechnetium-labeled plasmin test developed in 13 (37%) of 35 sequentially studied patients, all above 40 years, undergoing elective major abdominal surgery. Ten of the 13 patients with DVT had an abnormal pulmonary perfusion scintigram, suggesting pulmonary embolism (PE), but only three had clinical evidence of thrombotic disease.
 ...
PMID:Distinction by radioisotope technique of a subgroup with increased thrombophilic potential among patients submitted to major abdominal surgery. 295 36

Deep vein thrombosis of the upper extremity is rare. While its pathogenesis is not always evident, it often occurs in connection with tumors, thoracic outlet syndrome or intravenous catheter therapy. Acute thrombosis of the subclavian vein usually is a clinical diagnosis, but in doubtful cases diagnostic tests such as Doppler ultrasound and/or plethysmography may be useful. If necessary, verification of subclavian vein thrombosis can be done by phlebography. Considering the incidence of thromboembolic complications such as pulmonary embolism, anticoagulation is indicated in all cases of acute thrombosis. Under standard conservative treatment residual symptoms following the venous occlusion are few and the prognosis is favorable. Therefore, invasive treatment such as thrombectomy or thrombolysis should be considered only in special cases.
 ...
PMID:[Deep venous thrombosis of the upper extremities]. 305 67

The problem of thromboembolic complication in patients undergoing surgery for colorectal malignancies has been evaluated based on data from the literature and own experiences. One problem is the few studies dealing exclusively with this group of patients or presenting separate data on these patients. Deep vein thrombosis is somewhat more common than that seen after other types of abdominal surgery. No difference between patients operated on for colonic or rectal cancer have been found. The number of fatal or contributory pulmonary emboli is higher than the average number among other operated patients. Low dose heparin, low molecular weight heparin and mechanical methods, especially when combined with heparin or dextran, reduce the frequency of deep vein thrombosis. Fatal pulmonary embolism can effectively be prevented by low dose heparin with or without dihydroergotamine or by dextran.
 ...
PMID:Thromboembolic problems in colorectal cancer surgery. 305 61

Deep vein thrombosis (DVT) and pulmonary embolism (PE) are both characterized by unreliable clinical diagnosis and significant long-term sequelae. In patients with DVT, popliteal valvular insufficiency is associated with increased risk for postphlebitic syndrome. Current data show thrombolytic therapy to be more effective than anticoagulation for DVT, accomplishing significant or complete clearing of the deep venous system in nearly half of all patients treated. Results of investigation show lytic therapy to also be more effective than heparin in treatment of PE, both in terms of acute resolution and long-term function.
 ...
PMID:Deep vein thrombosis and pulmonary embolism: clinical presentation and pathophysiologic consequences. 313 Oct 10

Ninety-two patients undergoing vascular surgery took part in a controlled clinical trial to study the effectiveness of a new low molecular weight (LMW) heparin for prevention of post-operative deep vein thrombosis. Forty-six patients were treated daily, for 7 days after operation, with a single subcutaneous injection of 15,000 Anti X-activated Factor Units of the new LMW heparin; the remaining 46 patients were treated, for the same period, with 2 daily subcutaneous injections of 5,000 International Units of calcium heparin. Deep vein thrombosis detection was by the radioactive fibrinogen uptake test, performed each day during therapy in all patients. A very low incidence of sub-clinical deep vein thrombosis was observed; in 3 (6.5%) patients in the LMW heparin group and in 4 (8.6%) patients of the calcium heparin group. The results of laboratory investigation showed that the antithrombotic activity (inhibition of Factor Xa) of the LMW preparation was significantly greater than that of calcium heparin, while activated partial thromboplastin time was greater in the calcium heparin group. The new preparation also showed better local tolerance, with less pain on subcutaneous injections.
 ...
PMID:Low molecular weight heparin prevention of post-operative deep vein thrombosis in vascular surgery. 317 26

The effect of either (randomized) Heparin/Dihydroergotamine (HDHE) or heparin-acenocoumarin (Hep/S) on the incidence of deep-vein thrombosis in the legs was studied in 212 women of more than 60 years of age with hip fractures. All patients were screened with the 125-I-fibrinogen uptake test (FUT) confirmed by a bilateral ascending venogram upon positive FUT. This revealed good sensitivity and specificity (85/84%) for the FUT. Deep vein thrombosis developed in 37.6% of the HDHE group and in 59.1% of the Hep/S group which was significantly different (p less than 0.005). The calculated thrombosis risk was significantly diminished (by 38% - p less than 0.005) in the HDHE group. Therefore we conclude that in traumatology Heparin/Dihydroergotamine seems to be the prophylaxis of choice.
 ...
PMID:[Thrombosis prevention with heparin/dihydroergotamine versus heparin/Sintrom in Ender nailing of pertrochanteric fractures]. 328 33


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>